ResMed | RMD - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
Ansell USD 126.7M 93.35M 2025-12
Artivion USD 11.4M 7.84M 2025-12
AtriCure USD 394K 1.97M 2026-03
Baxter International USD 362M 368M 2026-06
Cochlear AUD 121.1M 155.6M 2025-06
Cooper Companies USD 192.2M 75.4M 2025-12
CSL USD 2.61B 1.21B 2025-12
Dexcom USD 269.5M 71.2M 2026-03
Edwards Lifesciences USD 529.3M 90.4M 2026-06
Fisher Paykel Healthcare NZD 347.7M 50.8M 2026-06
Globus Medical USD 157.07M 12.16M 2026-03
Haemonetics USD 47.57M 75.97M 2026-06
Idexx Laboratories USD 417.22M 61.78M 2026-06
Inogen USD -6.06M 467K 2024-09
Insulet USD 118.7M 5.7M 2026-06
Integra LifeSciences USD -2.41M 6.72M 2026-03
Intuitive Surgical USD 940.4M 15.2M 2026-03
Medtronic USD 2.45B 1.04B 2026-03
Philips EUR 546M 356M 2026-06
Ramsay Health Care AUD 240.5M 136.75M 2025-12
ResMed USD 502.31M 6.16M 2026-03
Sigma Healthcare AUD 8.15M 7.4M 2024-07
Sonic Healthcare AUD 402.01M 53.16M 2025-06
Steris USD 304.5M 46.7M 2026-03
Teleflex USD -3.83M 222.77M 2026-03
Thermo Fisher Scientific USD 1.73B 389M 2026-03